Recently, it has been reported that the order of acquisition of JAK2 and TET2 mutations may influence MPN phenotype, with “JAK2-first” more commonly detected in PV and “TET2-first” in ET patients [51]. Here, JAK2 is linked to myeloproliferative neoplasm.